THE EFFICACY OF FESOTERODINE FOR THE TREATMENT OF NEUROGENIC DETRUSOR OVERACTIVITY AND/OR LOW COMPLIANCE BLADDER.

被引：0
|
作者：
Kaga, K. [1 ]
Yamanishi, T. [1 ]
Fuse, M. [2 ]
Kaga, M. [2 ]
Shibata, C. [1 ]
Uchiyama, T. [1 ]
Ichikawa, T. [2 ]
机构：
[1] Dokkyo Med Univ, Continence Ctr, Dept Urol, Mibu, Tochigi, Japan
[2] Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan
来源：
NEUROUROLOGY AND URODYNAMICS | 2016年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
201
引用
收藏
页码：S183 / S185
页数：3
相关论文
共 50 条
  • [1] Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low compliance bladder
    Kaga, Kanya
    Yamanishi, Tomonori
    Kaga, Mayuko
    Fuse, Miki
    Kamasako, Tomohiko
    Ishizuka, Mitsuru
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (10) : 899 - 904
  • [2] Editorial Comment to Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladder
    Sekido, Noritoshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (10) : 905 - 905
  • [3] Efficacy of extended-release tolterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladder
    Watanabe, Miho
    Yamanishi, Tomonori
    Honda, Mikihiko
    Sakakibara, Ryuji
    Uchiyama, Tomoyuki
    Yoshida, Ken-Ichiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 (11) : 931 - 936
  • [4] Is Low Bladder Compliance Predictive of Detrusor Overactivity?
    Harding, C.
    Dorkin, T. J.
    Thorpe, A. C.
    NEUROUROLOGY AND URODYNAMICS, 2009, 28 (01) : 74 - 77
  • [5] SUPERIOR EFFICACY OF COMBINATION PHARMACOTHERAPY FOR TREATMENT OF NEUROGENIC DETRUSOR OVERACTIVITY
    Fraser, M. O.
    Lloyd, J. C.
    Le, N.
    Wiener, J. S.
    Dolber, P. C.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2014, 25 : S95 - S96
  • [6] Population Pharmacokinetic and Pharmacodynamic Modeling of Fesoterodine in Pediatric Patients with Neurogenic Detrusor Overactivity
    Sano, Yamato
    Shoji, Satoshi
    Shahin, Mohamed
    Sweeney, Kevin
    Darekar, Amanda
    Malhotra, Bimal K.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (03) : 257 - 269
  • [7] Antimuscarinics for the treatment of neurogenic detrusor overactivity
    Wyndaele, J. J.
    SPINAL CORD, 2013, 51 (06) : 431 - 431
  • [8] Antimuscarinics for the treatment of neurogenic detrusor overactivity
    J J Wyndaele
    Spinal Cord, 2013, 51 : 431 - 431
  • [9] Population Pharmacokinetic and Pharmacodynamic Modeling of Fesoterodine in Pediatric Patients with Neurogenic Detrusor Overactivity
    Yamato Sano
    Satoshi Shoji
    Mohamed Shahin
    Kevin Sweeney
    Amanda Darekar
    Bimal K Malhotra
    European Journal of Drug Metabolism and Pharmacokinetics, 2023, 48 : 257 - 269
  • [10] EFFICACY OF FESOTERODINE FUMARATE IN NEUROGENIC DETRUSOR OVERACTIVITY DUE TO SPINAL CORD LESION OR MULTIPLE SCLEROSIS - A PROSPECTIVE STUDY
    Konstantinidis, Charalampos
    Samarinas, Michael
    Thomas, Charalampos
    Tzitzika, Moira
    Giannitsas, Konstantinos
    Athanasopoulos, Anastasios
    JOURNAL OF UROLOGY, 2021, 206 : E1173 - E1173
12345